Hear from the authors of the American Society of Clinical Oncology (ASCO) JCO publication “Utility of automated data transfer for cancer clinical trials” as they review their research findings on EHR-to-EDC technology in #clinicaltrials and how it can reduce data management burden and enhance overall efficiency. 📆 Join us on July 17th at 11 am to walk away with: - Tangible examples of how EHR-to-EDC technology is increasing the efficiency of trial data acquisition and management and lowering the burden to site staff - Suggested change management strategies for successful implementation https://lnkd.in/etmGFYAR
Flatiron Health’s Post
More Relevant Posts
-
The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director https://lnkd.in/enykUk_h #Oncology #PrecisionMedicine
To view or add a comment, sign in
-
-
In a conversation with Cancer Network®️ during the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, our Co-Founder and Chief Medical Officer, Arturo LoAIza-Bonilla MD, spoke about his research in developing an AI-enabled system intended to reduce the time and resources needed to match patients to trials. He stated that it may be possible to more than double the number of patients matched to trials when integrating next-generation sequencing (#NGS) testing results into the matching process compared with manual processes. For more information, please click on the link below. 👉🏻 https://bit.ly/4co1U6n Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu #MassiveBio #AIinHealthCare #ClinicalOncology #CancerResearch
To view or add a comment, sign in
-
-
The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director https://lnkd.in/gFWKsQkn #Oncology #PrecisionMedicine
To view or add a comment, sign in
-
-
The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director #Oncology #PrecisionMedicine
To view or add a comment, sign in
-
-
The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director https://lnkd.in/ecFUNM26 #Oncology #PrecisionMedicine
To view or add a comment, sign in
-
-
Watch our latest on-demand webinar where MEDITECH Manager of Clinical Product Management, Jennifer Ford, MBA, and GenomOncology’s Vice President of Product Innovation, James Cole, PhD, discuss how our integrated solutions are reshaping cancer care, empowering clinicians and researchers to develop impactful treatment strategies. Watch now to learn more about: 👉 The groundbreaking collaboration between MEDITECH and GenomOncology 👉 The integration of the GenomOncology Precision Oncology Platform directly into MEDITECH’s #Expanse Genomics solution 👉 How clinicians can access actionable insights and treatment options at the point of care, seamlessly merged into existing workflows Watch here: https://lnkd.in/eijGhXpJ #webinar #precisionmedicine #clinicaltrials #therapies #precisiononcology
To view or add a comment, sign in
-
-
The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director https://lnkd.in/gGUVaMJX #Oncology #PrecisionMedicine
To view or add a comment, sign in
-
-
The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director https://lnkd.in/eSG4V2cr #Oncology #PrecisionMedicine
To view or add a comment, sign in
-
-
The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director https://lnkd.in/gmVMym_x #Oncology #PrecisionMedicine
To view or add a comment, sign in
-
-
How much have delayed or terminated #clinicaltrials cost your organization in: 1) Failing to efficiently identify patients eligible for clinical studies? 2) Opportunity cost and revenue lost for your therapeutic/drug approval? Using #AI / #NLP and a proprietary oncology focused knowledge model to efficiently identify eligible patients, OncoLens reduces barriers between patients, physicians, and study sponsors! Used by more than 200 NCI, academic and community cancer centers for oncology treatment planning, OncoLens has close relationships with many sites and can help advance your clinical trial goals. To learn more OncoLens’ clinical trial solutions, click here https://lnkd.in/gZm3rAd7, or contact [email protected]
To view or add a comment, sign in
-